title: [Successful management of a patient with myotonic dystrophy under total intravenous anesthesia with propofol, remifentnil and rocuronium bromide, combined with epidural anesthesia].
abstract: In general anesthesia for a patient with dystrophia myotonica (DM), respiratory depression and muscle weakness by opioid, as well as prolongation of the effect of muscle relaxant are seen postoperatively. Therefore it is desirable to choose agents with short duration of action and to dose these medicines to the minimum. We report a case of a 45-year-old woman with DM who underwent laparotomy for uterine cancer under general anesthesia combined with epidural anesthesia. Epidural catheter was placed from T 11-12, and anesthesia was inducted with propofol and remifentanil (RF). We administered rocuronium bromide (RB) 5 mg while watching TOF ratio with a muscle relaxation monitor (TOF-Watch). T1 became 0 after giving a dose of 10 mg, and intubation was performed. We maintained anesthesia by propofol and RF combined with epidural anesthesia. TOF ratio was restored to around 80% 90 minutes after RB administration, but we did not give supplemental doses because the operation went well smoothly. Recovery was smooth and fast. The respiratory depression and the muscle spasm were not noticed. RB and RE both with short duration of action, are useful in anesthesia management in DM cases.
authors.affiliation: Department of Anesthesia, Saiseikai Yokohamashi Nanbu Hosipital, Yokohama 234-8503.
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Nakanishi
authors.forename: Masamitsu
authors.initials: M
authors.lastname: Nishihama
authors.forename: Akiko
authors.initials: A
authors.lastname: Hirai
authors.forename: Mihoko
authors.initials: M
authors.lastname: Uchikado
authors.forename: Mika
authors.initials: M
authors.lastname: Shimosaka
authors.forename: Arisa
authors.initials: A
authors.lastname: Uehara
mesh_terms: D000732:Androstanols / Q000008:administration & dosage*; D000767:Anesthesia, Epidural; D000771:Anesthesia, Intravenous / Q000379:methods*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009223:Myotonic Dystrophy / Q000150:complications*; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage*; D010880:Piperidines / Q000008:administration & dosage*; D015742:Propofol / Q000008:administration & dosage*; D000077208:Remifentanil; D000077123:Rocuronium; D014594:Uterine Neoplasms / Q000601:surgery
chemical_list: D000732:Androstanols; D018686:Anesthetics, Intravenous; D003473:Neuromuscular Nondepolarizing Agents; D010880:Piperidines; D000077208:Remifentanil; D000077123:Rocuronium; D015742:Propofol